Patient-rated treatment satisfaction post baseline—TSQM-9 (full-analysis set, N=146)*
| TSQM-9 domain score (mean percentage (SD)) | Verum (n=72) | Placebo (n=74) |
| Effectiveness | ||
| After 2 weeks | 65.66 (24.99) | 51.00 (23.61) |
| After 4 weeks | 70.22 (24.10) | 55.09 (26.86) |
| After 6 weeks | 74.10 (26.87) | 54.85 (28.28) |
| Convenience | ||
| After 2 weeks | 88.27 (15.08) | 86.23 (16.52) |
| After 4 weeks | 90.20 (13.43) | 85.88 (15.00) |
| After 6 weeks | 89.91 (14.06) | 89.36 (14.20) |
| Global satisfaction | ||
| After 2 weeks | 69.35 (22.85) | 53.17 (24.18) |
| After 4 weeks | 75.00 (21.41) | 58.63 (27.81) |
| After 6 weeks | 79.38 (21.35) | 59.18 (29.87) |
*The full-analysis set includes all randomised patients who received the study drug at least once, and who provided any postbaseline data for the RDQ score used for responder analysis, and who did not violate against inclusion criteria.
n/N, number of patients; RDQ, Reflux Disease Questionnaire; SD, standard deviation; TSQM-9, Treatment Satisfaction Questionnaire for Medication version 9.